VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 15, 2008) - Allon Therapeutics Inc. (TSX:NPC), today announced that it has completed the bought deal public offering of common shares first announced in its press release dated June 23, 2008. Allon sold 19,050,000 common shares ("Common Shares") at a price of $1.05 per Common Share, resulting in gross proceeds to Allon of $20,002,500.
